Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessDr Reddy's launches cancer treatment injection Bortezomib in US

    Dr Reddy's launches cancer treatment injection Bortezomib in US

    The Hyderabad-based drug major has launched the product after getting approval from the US Food and Drug Administration (USFDA).

    PTI
    July 27, 2022 / 11:17 IST
    Dr Reddy's Laboratories: Dr Reddy's Labs launches Fesoterodine Fumarate tablets in US. The pharma company has launched Fesoterodine Fumarate extended-release tablets in the US market, which are used in the treatment of certain bladder related problems. This drug is a therapeutic generic equivalent to Toviaz brand which had US sales of approximately $211 million MAT for the most recent twelve months ending in May 2022, according to IQVIA.
       
       
      26 Aug, 2025 12:21
      Volume
      Todays L/H
      More

      Dr Reddy's Laboratories on Wednesday said it has launched Bortezomib for Injection, used to treat certain types of cancer, in the US market.

      The Hyderabad-based drug major has launched the product after getting approval from the US Food and Drug Administration (USFDA).

      The company's product is the generic version of Velcade brand. According to IQVIA Health, Velcade and other generics have sales of around USD 1.2 billion in the US.

      Dr Reddy's Bortezomib for Injection, is supplied in a 3.5 mg per 10 mL single-dose vial presentation for subcutaneous (SQ) or intravenous (IV) use, it noted.

      PTI
      first published: Jul 27, 2022 11:17 am

      Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

      Subscribe to Tech Newsletters

      • On Saturdays

        Find the best of Al News in one place, specially curated for you every weekend.

      • Daily-Weekdays

        Stay on top of the latest tech trends and biggest startup news.

      Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347